Last updated: 2025-11-21 19:14:36 ET
A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss drug market.
The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounj...
Celebrities spent years singing “love yourself” from the stage and lecturing all of us about radical body acceptance. But then, a funny thing happ...
Transportation decisions in 2026 carry more weight. The right system can steady your network and keep you ahead of constant disruption. The 2026 Trans...
Tom Garrigan is executive director at the Building Services Research and Intelligence Association The UK’s retrofit ambitions risk collapse under th...
The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling divisions between his supporter...
